lobbying_activities: 2024488

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2024488	5222be7d-8ffa-4c37-a765-637003c87daf	Q3	AKIN GUMP STRAUSS HAUER & FELD	682	PHARMEDIUM SERVICES, LLC	2017	third_quarter	PHA	Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2017-10-16T10:57:33.780000-04:00